Berkley W R Corp
—- Market cap
- —
- Debt
- —
- Cash
- −$2.54B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WRB stock price vs CB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CB's multiple
Needs CB P/E.
Implied fair value · at WRB's multiple
Needs WRB P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BERKLEY W R CORP · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
CHUBB LIMITED · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TRAVELERS COMPANIES, INC.
WRB vs TRV
HARTFORD FINANCIAL SERVICES GROUP, INC.
WRB vs HIG
MARKEL GROUP INC.
WRB vs MKL
AMERICAN INTERNATIONAL GROUP, INC.
WRB vs AIG
ALLSTATE CORP
WRB vs ALL
PROGRESSIVE CORP/OH/
WRB vs PGR
CINCINNATI FINANCIAL CORP
WRB vs CINF
Arthur J. Gallagher & Co.
WRB vs AJG
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WRB can sustain faster revenue growth while materially improving margins and reducing leverage, then the stock could be worth holding or adding despite the current P/E-based downside, because the present valuation discount is not supported by current balance-sheet and profitability metrics.
WRB trades below CB-implied value of $58.54-$81.13 only versus the broader comparison range if judged against the current price, but the provided P/E-based implied price of $54.50 still suggests 17.8% downside from $66.31. The discount picture is mixed because WRB looks cheaper on P/E than CB, yet it looks more expensive on EV-based metrics that incorporate debt.
Supporting Metrics